Table:
begin	end	state
1	11	cytoplasmic
12	33	transmembrane
34	37	non-cytoplasmic
38	67	transmembrane
68	86	cytoplasmic
87	107	transmembrane
108	126	non-cytoplasmic
127	150	transmembrane
151	167	cytoplasmic
168	191	transmembrane
192	202	non-cytoplasmic
203	225	transmembrane
226	245	cytoplasmic
246	268	transmembrane
269	273	non-cytoplasmic
274	292	transmembrane
293	303	cytoplasmic
304	325	transmembrane
326	344	non-cytoplasmic
345	363	transmembrane
364	365	cytoplasmic
366	385	transmembrane
386	389	non-cytoplasmic
390	414	transmembrane
415	431	cytoplasmic
432	453	transmembrane
454	459	non-cytoplasmic

Input:
>WP_086509096.1 NCBI__GCF_002151265.1:WP_086509096.1
MARLSVMRWHKPIVTPTLSALAVLGCVILAVMGHYLSFLFFSLFTMLVLGMPIAISLAGS
CLLFVLISGQVPDIVVAHRMINGIDSFPLLAIPFFIFAGSLMNNAGITERIFNFAKALMG
WMRGGLGHVNVGASIVFSGMSGAAVADAGGLGMIEVKAMKDAGYDEEFAVGITAASSTIG
PIIPPSLPMVIYGVMASASVGQLFAAGLLPGLLMGVMLMVMIFFIARRRGYQRDTTFSLR
VLGHTFGRAVLSLMTPVIIVGGIITGAFTPTEAAVAAVFYALFLGVVVYRTLTWRKLIKV
SMETIETTAVILFIVAAASIFAWILTSNQVTQHVIALMGPFSDSKVVVLMMTNLVLIIVG
CFMETIAAITILVPVLLPLAVAVGVDPVHFGVIMVLNLMIGLLTPPVGMVLYVLSRVSNV
SFERCMRGTIPFLIPLVLCLLLVTFVPAISMWLPTLVYR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server